Mechanisms of Action of Anticancer Antibiotics
Why is a material that is produced by one organism toxic to another organism?
Can these toxic effects be prevented or overcome?
Are the various toxic materials toxic for the same reason?
Why are some organisms not affected by these agents while other organisms are killed by them?
Why are some tissues or cells within an organism affected by the agents while other tissues and cells are not?
How do organisms become resistant to an initially toxic agent?
KeywordsOrotic Acid Purine Synthesis Purine Biosynthesis Urocanic Acid Antitumor Antibiotic
Unable to display preview. Download preview PDF.
- Anderson, E. P., Levenberg, B., and Law, L. W. 1957 Purine biosynthesis in azaserine-sensitive and -resistant lines of the mouse plasma cell neoplasm 70429. Fed. Proc., 16, 145.Google Scholar
- Barclay, R. K., Garfinkel, E., and Phillipps, M. 1956 Effects of DON on incorporations of precursors into nucleic acids. Proc. Am. Assoc. Cancer Research, 2, 93.Google Scholar
- Bennett, L. L., Jr., Schabel, F.M.,Jr., and Skipper, H. E. 1956 Studies on the mode of action of azaserine. Arch. Biochem. and Biophys., 64, 423.Google Scholar
- Bentley, M., and Abrams, R. 1956 Amide-N of glutamine as source of guanine amino group. Fed. Proc., 15, 218.Google Scholar
- Bortle, L., and Oleson, J.J. 1955 Effect of puromycin on Tetrahymena pyriformis nutrition. Antibiotics Annual 1954–55, 770.Google Scholar
- Buchanan, J.M. 1958 The interference of azaserine in purine biosynthesis, in “Amino Acids and Peptides with Antimetabolic Activity,” CibaSymposium, J. and A. Churchill, Ltd., London, 75–81.Google Scholar
- Burchenal, J. H., Holmberg, E.A.D., Reilly, H. C., Hemphill, S., and Reppert, J. A. 1959 The effects of actinobolin on transplanted mouse leukemias. Antibiotics Annual 1958–59, 528.Google Scholar
- Clarke, D. A., Reilly, H. C., and Stock, C. C. 1957 A comparative study of 6-diazo-5-oxo- L-norleucine and O-diazoacetyl-L-serine on sarcoma 180. Antibiot. and Chemotherapy, 7, 653.Google Scholar
- Dagg, C. P., and Karnofsky, D. A. 1956 Protection against teratogenic action of azaserine and DON. Fed. Proc., 15, 238.Google Scholar
- Davis, J. C., and Mudd, S. 1956 Cytological effects of ultraviolet radiation and azaserine on Corynebacterium diphtheriae. J. Gen. Microbiol., 14, 527.Google Scholar
- DiPaolo, J. A., Moore, G. E., and Niedbala, T. F. 1957 Experimental studies with actinomycin D. Cancer Research, 17, 1127.Google Scholar
- Eidinoff, M. L., Knoll, J. E., Marano, B., and Cheong, L. 1958 Pyrimidine studies. I. Effect of DON (6-diazo-5-oxo-L-norleucine) on incorporation of precursors into nucleic acid pyrimidines. Cancer Research, 18, 105.Google Scholar
- Farber, S. 1958 Clinical and biological studies with actinomycins, in “Amino Acids and Peptides with Antimetabolic Activity,” Ciba Symposium, J. and A. Churchill Ltd., London, 138–145.Google Scholar
- Foley, G. E. 1956 Preliminary observations on the mechanism of action of actinomycin D in microbiologic systems. Antibiotics Annual 1955–56, 432.Google Scholar
- Goldthwait, D. A. 1957 Purine nucleotide biosynthesis and neoplasia, in “Henry Ford Hospital International Symposium on the Leukemias: Etiology, Pathophysiology, Treatment,” pp. 555–565. Edited by J. W. Rebuck, F. H. Bethell, and R. W. Monto, Academic Press, Inc., New York.Google Scholar
- Gots, J.S., and Gollub, E. G. 1956 Purine metabolism in bacteria. IV. L-Azaserine as an inhibitor. J. Bact., 72, 858.Google Scholar
- Hedegaard, J., Thoai, N-v., and Roche, J. 1959 The influence of histidine on the biosynthesis of purines in Escherichia coli. Arch. Biochem. and Biophys., 83, 183.Google Scholar
- Hewitt, R.I., Gumble, A. R., Wallace, W.S., andWilliams, J. H. 1954 Experimental chemotherapy of trypanosomiasis. IV. Reversal by purines of the in vivo activity of puromycin, and an amino nucleoside analog, against Trypanosoma equiperdum. Antibiot. and Chemotherapy, 4, 1222.Google Scholar
- Kaplan, L., and Stock, C. C. 1954 Azaserine, an inhibitor of amino acid synthesis in Escherichia coli. Fed. Proc., 13, 239.Google Scholar
- Karnofsky, D. A., and Bevelander, G. 1958 Effects of DON(6-diazo-5-oxo-L-norleucine) and azaserine on the sand-dollar embryo. Proc. Soc. Exp. Biol, and Med., 97, 32.Google Scholar
- Langan, T. A., Jr., Kaplan, N. O., and Shuster, L. 1959 Formation of the nicotinic acid analogue of diphosphopyridine nucleotide after nicotinamide administration. J. Biol. Chem., 234, 2161.Google Scholar
- Mascitelli-Coriandoli, E. 1959 Effects of actinomycin-C upon the pyridoxal phosphate contents of the liver. Biochem. Pharmacol., 2, 79.Google Scholar
- Maxwell, R. E., and Nickel, V.S. 1957 6-Diazo-5-oxo-L-norleucine, a new tumor “inhibitory substance. V. Microbiologic studies of mode of action. Antibiot. and Chemotherapy, 7, 81.Google Scholar
- Potter, M., and Law, L.W. 1957 Studies on a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide. J. Nat. Cancer Inst., 18, 413.Google Scholar
- Preiss, J., and Handler, P. 1958 Biosynthesis of diphosphorpyridinenucleotide. II. Enzymatic aspects. J. Biol. Chem., 233, 493.Google Scholar
- Raven, H. M., and Hess, G. 1959 Die Wirkung der Actinomycin C und D auf Neurospora crassa. Z. fur Physiolog. Chem., 315, 70.Google Scholar
- Reilly, H. C. 1954 The effect of amino acids upon the antimicrobial activity of azaserine. Proc. Am. Assoc. Cancer Research, 1, No. 2, 40.Google Scholar
- Reilly, H. C. 1958 Some aspects of azaserine, 6-diazo-5-oxo-L-norleucine, and fl-2- thienylalanine, in “Amino Acids and Peptides with Antimetabolic Activity.” Ciba Symposium, J. and A. Churchill, Ltd., London, 62–74.Google Scholar
- Reilly, H. C., Cappuccino, J. G., and Harrison, D. M. 1958 Studies on mitomycin X, A tumor-inhibiting antibiotic. Proc. Am. Assoc. Cancer Research, 2, 338.Google Scholar
- Slotnick, I. J. 1957 Studies on the mechanism of actinomycin D inhibition of Bacillus subtilis. I. Failure to demonstrate pantothenate relationship. Antibiot. and Chemotherapy, 7, 387.Google Scholar
- Slotnick, I.J. 1958 Studies on the mechanism of action of actinomycin D. II. Interference with ammonia assimilation and adaptive enzyme formation. Antibiot. and Chemotherapy, 8, 476.Google Scholar
- Srinivasan, P. R. 1959 The enzymatic synthesis of anthranilic acid from shikimic acid-5- phosphate and L-glutamine. J. Am. Chem. Soc., 81, 1772.Google Scholar
- Thiersch, J. B. 1957a Effect of o-diazck acetyl-L-serine on rat litter. Proc. Soc. Exp. Biol, and Med., 94, 27.Google Scholar
- Thiersch, J. B. 1957b Effect of 6-diazo-5-oxo-L-norleucine (DON) on the rat litter in utero. Proc. Soc. Exp. Biol, and Med., 94, 33.Google Scholar
- Tomisek, A. J., Kelly, H. J., and Skipper, H. E. 1956 Chromatographic studies of purine metabolism. I. The effect of azaserine on purine biosynthesis in E. coli using various C14-labeled precursors. Arch. Biochem. and Biophys., 64, 437.Google Scholar
- Van der Meulen, P. Y. F., and Bassham, J. A. 1959 Study of inhibition of azaserine and diazo-oxo-nor leucine (DON) on the algae Scenedesmus and Chlorella.J. Am. Chem. Soc., 81, 2233.Google Scholar